Scientific Sessions

Pediatric pharmacology is a rapidly advancing field dedicated to understanding how drugs interact with the unique physiology of infants, children, and adolescents. Unlike adults, children have distinct metabolic rates, organ maturity levels, and developmental stages that influence how medications are absorbed, distributed, metabolized, and excreted. As such, simply adjusting adult doses for pediatric patients can lead to inefficacy or toxicity. Modern pediatric pharmacology focuses on evidence-based dosing strategies, age-specific formulations, and safety assessments tailored to different pediatric age groups. Clinical trials designed specifically for children are now prioritized to ensure accurate data on drug efficacy and safety, ultimately improving therapeutic outcomes and minimizing adverse effects.

Novel drug development for pediatric populations has gained significant momentum with the integration of advanced technologies and regulatory support. Innovations such as nanomedicine, targeted drug delivery systems, and pharmacogenomics are enabling more precise and effective treatments for pediatric diseases. The introduction of pediatric investigation plans (PIPs) by regulatory agencies encourages pharmaceutical companies to include children in early drug development stages, ensuring timely access to suitable therapies. Furthermore, the development of child-friendly formulations—such as flavored suspensions, dissolvable tablets, and transdermal patches—has improved medication adherence among young patients. Collaboration between clinicians, researchers, and industry partners continues to drive progress toward safer, more personalized pediatric therapeutics. As the understanding of pediatric pharmacology deepens, the future of child-specific drug development promises not only better disease management but also a stronger foundation for lifelong health.